Status:
COMPLETED
Analysis of Spatiotemporal Gait Parameters in Patients With Megaprosthesis.
Lead Sponsor:
Cardenal Herrera University
Conditions:
Distal Femoral Musculoskeletal Tumors
Megaprosthesis
Eligibility:
All Genders
16-99 years
Brief Summary
The main objective of the study is to evaluate spatiotemporal parameters of gait in tumoral patients with megaprosthesis of the distal femur.
Detailed Description
Patients with distal femoral prostheses treated at La Fe Hospital in Valencia were evaluated and compared with healthy controls. A radiographic study was conducted in cases using telemetric imaging to...
Eligibility Criteria
Inclusion
- Megaprosthesis of the distal femur
- Tumor cause
- Surgery at Hospital la Fe.
- Traditional stem or biological ossteointegration system
- Minimum postoperative follow-up period of 3 months
Exclusion
- Neurological alterations prior to the intervention that affect the lower limbs or general movement.
- Patient incapable of ambulation due to progression of his/her pathology
- Patient at home with palliative treatment for advanced tumor disease
- Any ipsilateral or contralateral prosthesis.
- Infectious or traumatic cause
Key Trial Info
Start Date :
February 8 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2024
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT05202873
Start Date
February 8 2018
End Date
November 1 2024
Last Update
December 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidad Ceu Cardenal Herrera
Valencia, Spain, 46006